dacarbazine has been researched along with Anemia, Aplastic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgar, V; Dixit, S; Hingorani, M | 1 |
| Buckner, JC; Gangat, N; Kourelis, TV; Patnaik, MM | 1 |
| Brandal, P; Johannesen, TB; Tjønnfjord, GE; Vandraas, K | 1 |
| Broniscer, A; Ellison, D; Kasow, K; Morris, EB; Reiss, U | 1 |
| Eichinger, JB; George, BJ; Richard, TJ | 1 |
| Kopecký, J; Kopecký, O; Macingova, Z; Petera, J; Priester, P; Slovácek, L | 1 |
| Archimbaud, A; Basset-Seguin, N; Dubertret, L; Guitera, P; Kerob, D; Levy, A; Ollivaud, L | 1 |
| Collins, CA; Manasanch, EE; Ramaprasad, C; van Besien, K; Villano, JL | 1 |
| Gujral, S; Jalali, R; Menon, H; Singh, P | 1 |
9 other study(ies) available for dacarbazine and Anemia, Aplastic
| Article | Year |
|---|---|
An analysis of temozolomide-related adverse drug reactions reported to the medicines and healthcare products regulatory agency through the yellow card scheme aiming to characterise idiosyncratic profound bone marrow suppression tantamount to aplastic anae
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Bone Marrow; Dacarbazine; Humans; Middle Aged; Temozolomide; Young Adult | 2014 |
Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Astrocytoma; Bone Marrow; Brain Neoplasms; Dacarbazine; Female; Humans; Male; Middle Aged; Survival Analysis; Temozolomide; Treatment Outcome | 2015 |
Persistent bone marrow depression following short-term treatment with temozolomide.
Topics: Aged; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Brain Neoplasms; Dacarbazine; Fatal Outcome; Filgrastim; Glioblastoma; Hemoglobinuria, Paroxysmal; Humans; Male; Receptors, Fc; Recombinant Fusion Proteins; Temozolomide; Thrombopoietin; Treatment Failure | 2016 |
Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Dacarbazine; Female; Glioma; Humans; Temozolomide | 2009 |
A rare case of aplastic anemia caused by temozolomide.
Topics: Aged; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Dacarbazine; Female; Glioblastoma; Humans; Temozolomide | 2009 |
Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.
Topics: Anemia, Aplastic; Antineoplastic Agents, Alkylating; Blood Cell Count; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Frontal Lobe; Glioblastoma; Hemorrhagic Disorders; Humans; Magnetic Resonance Imaging; Middle Aged; Parietal Lobe; Temozolomide | 2010 |
[Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Cross-Sectional Studies; Dacarbazine; Drug Hypersensitivity; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms; Time Factors | 2006 |
Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
Topics: Anemia, Aplastic; Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Glioblastoma; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Risk Factors; Temozolomide | 2006 |
Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.
Topics: Adult; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Blood Cell Count; Bone Marrow; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Fatal Outcome; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Pancytopenia; Sepsis; Temozolomide | 2007 |